The Association of Serum Uric Acid with Beta-Cell Function and Insulin Resistance in Nondiabetic Individuals: A Cross-Sectional Study
Peng Yu,Li Huang,Zhihan Wang,Xiaoyu Meng,Xuefeng Yu
DOI: https://doi.org/10.2147/DMSO.S312489
2021-06-14
Abstract:Peng Yu, 1, 2 Li Huang, 1, 2 Zhihan Wang, 1, 2 Xiaoyu Meng, 1, 2 Xuefeng Yu 1, 2 1 Department of Internal Medicine, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, People's Republic of China; 2 Branch of National Clinical Research Center for Metabolic Diseases, Hubei, China Correspondence: Xuefeng Yu Tel/Fax +8602783663331 Email Purpose: Higher serum levels of uric acid (SUA) are associated with an increased risk of developing type 2 diabetes. Meanwhile, insulin resistance and beta-cell dysfunction are critical factors that mediate the progression from normal glucose tolerance to impaired fasting glucose (IFG) and type 2 diabetes. We aimed to investigate the association between SUA levels and insulin resistance and beta-cell dysfunction in individuals without diabetes, thus explicating the role of uric acid in the early stage of the natural history of type 2 diabetes. Patients and Methods: We used cross-sectional data from the China Health and Nutrition Survey to examine the association. Insulin resistance and beta-cell dysfunction were estimated using the homeostasis model assessment of insulin resistance (HOMA-IR) index and homeostasis model assessment of beta-cell function (HOMA-beta) index, respectively. The associations were analyzed by using partial correlation analysis and multivariate logistic regressionl analysis. Results: SUA levels were positively associated with fasting glucose, fasting insulin, HOMA-IR in the total population. After adjustment for age, drinking, smoking, living area, daily dietary nutrient intake, body mass index (BMI), estimated glomerular filtration rate (eGFR), hypertension, and dyslipidemia, compared with participants in the lowest quartile of SUA, the adjusted odds ratios for the fourth quartiles were 1.56(1.09-2.24) for IFG, 1.51(1.27-1.78) for insulin resistance, and 1.06(0.88-1.27) for beta-cell dysfunction. In the subgroup analysis, no interactions were found between serum uric acid and age, drinking status, smoking status, BMI, hypertension, or dyslipidemia (all p for interaction> 0.05). Conclusion: In nondiabetic individuals, SUA levels are independently associated with IFG and insulin resistance, while no significant association exists between SUA and beta-cell dysfunction. Keywords: uric acid, beta-cell function, insulin resistance, nondiabetic Uric acid is the end product of the degradation of purine mononucleotides catalyzed by xanthine oxidoreductase, and it has two interconvertible forms: xanthine dehydrogenase and xanthine oxidase. Under stress conditions, including hypoxia and ischemia, xanthine oxidase predominates, and reactive oxygen species (ROS) are concomitantly generated in the process of uric acid production; moreover, uric acid is a potent antioxidant and acts as a free radical scavenger in human blood. 1–3 The main source of uric acid is endogenous purines, but it can also be derived from dietary sources. In recent years, with changes in lifestyles and diet, especially increased intake in foods rich in purine, an increasing trend in the prevalence of hyperuricemia has been witnessed worldwide. 4 In China, the estimated prevalence of hyperuricemia ranges from 5.5% to 23.6% in different regions. 5 Hyperuricemia has drawn much attention in recent decades, as patients with hyperuricemia often present with metabolic diseases, cardiovascular diseases and cardio-metabolic related complications. 6 , 7 Regarding diabetes, various longitudinal studies have demonstrated that higher baseline levels of serum uric acid increased the risk of developing type 2 diabetes, and a meta-analysis of 11 cohort studies including 42,834 participants indicated a 17% increase in the risk of type 2 diabetes for each 1 mg/dl increase in SUA. 8–10 Thus, how uric acid contributes to the pathophysiology of type 2 diabetes deserves research. Insulin resistance, and beta-cell dysfunction are two major pathophysiological defects in the development of type 2 diabetes. The interplay between genetic predisposition and lifestyle factors induces metabolic stress and systematic inflammation, thus initiating the disease. 11 Subsequently, hyperglycemia occurs, and patient presents with IFG and/or impaired glucose tolerance owing to the reduction in whole-body insulin sensitivity and increased secretory burden of beta-cells. Studies have reported that prediabetes has been associated with a 40% re -Abstract Truncated-